Added Webcast Archive and Presentations to Public Workshop – Mass Spectrometry in the Clinic: Regulatory Considerations Surrounding Validation of Liquid Chromatography

The Food and Drug Administration (FDA) announced a public workshop entitled “Mass Spectrometry in the Clinic: Regulatory Considerations Surrounding Validation of Liquid Chromatography-Mass Spectrometry Based Devices.” The topics discussed were the specific analytical and clinical study designs and considerations for validation and use of liquid chromatography/mass-spectrometry (LC/MS)-based in vitro diagnostic devices (IVDs) in the clinical…

Mammography Facility Adverse Event and Action Report

BackgroundAs part of the Mammography Quality Standards Act (MQSA), Congress mandated there be annual reporting of adverse actions taken against mammography facilities. Congress stipulated that the report be made available to physicians and the general public and that it should include information that is useful in evaluating the performance of mammography facilities nationwide. In order…